Administration of hydrogen-rich water prevents vascular aging of the aorta in LDL receptor-deficient mice.
Iketani M, Sekimoto K, Igarashi T, Takahashi M, Komatsu M, Sakane I, Takahashi H, Kawaguchi H, Ohtani-Kaneko R, Ohsawa I · Scientific reports · 2018
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
The publication “Administration of hydrogen-rich water prevents vascular aging of the aorta in LDL receptor-deficient mice.” is organized in H2HUBB under the research focus hydrogen water aging and longevity study 2018. The publication is cited as Iketani M, Sekimoto K, Igarashi T, Takahashi M, Komatsu M, Sakane I, Takahashi H, Kawaguchi H, Ohtani-Kaneko R, Ohsawa I, Scientific reports, 2018. This in vitro or cellular study examined Administration of hydrogen-rich water prevents vascular aging of the aorta in LDL receptor-deficient mice. The abstract describes Endothelial cell model; hydrogen delivered as hydrogen water; reported duration 13 weeks. The abstract reports: Recent studies showed that senescent cells are involved in the development and progression of atherosclerosis, and eliminating senescent cells suppresses the senescence-associated secretory phenotype. This is an automated editorial draft based on the abstract and requires source review before publication.
Hydrogen water aging and longevity study 2018 overview
Here, we used LDL receptor-deficient mice fed a high-fat diet (HFD) for 13 weeks as a model for atherosclerosis and evaluated the effects of… Laboratory and cellular research can clarify mechanisms, but it does not establish clinical benefit or reproduce the complexity of a living human system.
Study design and hydrogen intervention
Publication type: In vitro or cellular study. Evidence type: Laboratory or cellular evidence. Research model or population: Endothelial cell model. Blinding: Unknown. Control status: Unknown.
Delivery method: Hydrogen water. Treatment duration: 13 weeks.
Reported findings and scientific interpretation
For this hydrogen water aging and longevity study 2018, the study record reports the following: The abstract reports: Recent studies showed that senescent cells are involved in the development and progression of atherosclerosis, and eliminating senescent cells suppresses the senescence-associated secretory phenotype.
These findings should be interpreted as one piece of evidence rather than as a stand-alone medical conclusion. Results can be influenced by the research model, study design, treatment protocol, sample size, outcome selection, statistical methods, and whether the findings have been independently reproduced.
How this research record was prepared
H2HUBB organizes bibliographic details, study design information, intervention data, outcomes, limitations, and safety notes from the available scientific source. Automated classification supports database organization, but it does not replace critical reading of the complete paper. Source identifiers, evidence labels, and delivery-method fields are retained so readers can verify the record and compare it with related publications. A missing field means the information was unavailable or not reported in the structured source; it should not be treated as a negative finding.
Limitations, safety, and original source
Limitations: Laboratory findings may not translate directly to living organisms or clinical outcomes.
Safety: The abstract did not provide detailed safety or adverse-event information.
This H2HUBB page is an educational research record, not medical advice. Review the original scientific source for the complete methods and results. Continue exploring the H2HUBB Molecular Hydrogen Research Library to compare evidence types, delivery methods, and related topics.